New York Main Representative at UN for NGO Women’s Health and Education Center (WHEC) 300 Stafford Street; Suite 265 Springfield, MA 01104 USA Telephone: 413-733-1177 Fax: 413-733-0425 e-mail:jriverawhec@gmail.com Born in Puerto Rico in 1971, Joanne Rivera has resided in New York City since 1990. Mother of 3 children, one boy and two girls, she has dedicated her work to improve maternal and child health. All throughout school and college education at Greenfield Community college and Bay State Mini Medical School in Massachusetts, the emphasis was on: make all efforts to understand different customs and learn to respect the differences. She is bilingual (English and Spanish) and welcomes challenges to resolve conflicts. Her extensive training includes: management, scheduling, money-management, organize and supervise care for the disabled. She has provided care for consumers with severe medical disabilities, hip and knee joint replacements, seizures, cerebral palsy, and incontinence. Her expertise also includes accurate records of medication, progress notes, safety plan and wound care. She has worked for 4 years with Behavioral Health Network and Western Massachusetts Elder Care, Inc. before joining Women’s Health and Education Center (WHEC). Joined in 2007 as Office Manager of Women’s Health and Education Center (WHEC) she has worked tirelessly to get various projects and programs of WHEC, in maternal and child health, off the ground. That is how the interest in international project and program development started. As we begin our next chapter of the development of this Global Initiative, we all welcome her in the challenging role of Main NGO Representative of WHEC at the United Nations. Working at WHEC her duties include: coordinating collaboration with a diverse group of professionals from United Nations, intra-country, national, regional and local agencies, universities, schools of public health, community organizations and professional societies. We hope our efforts are helpful in implementing improved and informed care. We hope that our initiatives will provide a useful factual basis for action, for all those working for Safe Motherhood.Read More
Professor of Obstetrics and Gynecology Chief, Division of Maternal-Fetal Medicine University of Utah Health Sciences Center (UUHSC) 30 North 1900 East SOM 2B200 Salt Lake City, UT 84132 (USA) Tel: 801-585-5156 Fax: 801-585-2594 E-mail: robert.silver@hsc.utah.edu Education and Training: INSTITUTION AND LOCATION DEGREE YEAR (s) FIELD OF STUDY University of Pennsylvania, Philadelphia, PA BA 1982 Microbiology Medical College of Pennsylvania, Philadelphia, PA MD 1986 Medicine University of Colorado Health Sciences Center, Denver, CO Residency 1986-1990 Obstetrics and Gynecology University of Utah Health Sciences Center (UUHSC), Salt Lake City, UT Fellowship 1990-1994 Maternal-Fetal Medicine A. Positions and Honors Positions 1990-1991 Clinical Instructor, Department of Ob/Gyn, UUHSC, SLC, UT 1992-1994 Instructor, Department of Ob/Gyn, UUHSC, SLC, UT 1994-1998 Assistant Professor, Department of Ob/Gyn, UUHSC, SLC, UT 1998-2006 Associate Professor with tenure, Department of Ob/Gyn, UUHSC, SLC, UT 2006-present Professor with tenure, Department of Ob/Gyn, UUHSC, SLC , UT 1995-2003 Residency Director, Department of Ob/Gyn, UUHSC, SLC, UT 2001-present Medical Director of Labor and Delivery, UUHSC, SLC, UT 2000-present Division Chief, Maternal Fetal Medicine, Department of Ob/Gyn, UUHSC, SLC, UT Honors 1985 Kurt Pauker Achievement Award for Excellence in Microbiology 1986 Alpha Omega Alpha 1993-1998 Research Scientist Development Program, National Institutes of Health 2000 Poster Award (best of session): IgA beta-2-glycoprotein-I Antibodies are Elevated in Women with Unexplained Recurrent Spontaneous Abortion and Unexplained Fetal Death, Society for Gynecologic Investigation 2001 Poster Award (best of session): Heparin-induced Thrombocytopenia is Rare in Pregnancy, Society of Perinatal Obstetricians 18th Annual Meeting 2003 Poster Award (best of meeting): Stillbirth in Utah from 1995-2001 B. Peer-Reviewed Publications Select peer-reviewed publications (in chronological order) Mitchell MD, Edwin SS, Lundin-Schiller S, Silver RM, Smotkin D, Trautman MS. (1993). Mechanism of interleukin-1 beta stimulation of human amnion prostaglandin biosynthesis: mediation via a novel inducible cyclooxygenase. Placenta 1993; 14:615-25. Edwin SS, Branch DW, Scott JR, Silver RM, Mitchell MD. Cyclosporin A attenuates increased prostaglandin and thromboxane production in response to various stimuli in human decidua. Am J Reprod Immunol 1993;30: 154-9. Silver RM, Draper ML, Scott JR, Lyon JL, Byrne SL, Ashwood EA, Branch DW. Unexplained elevations of maternal serum alpha-fetoprotein in women with antiphospholipid antibodies: A harbinger of fetal death. Obstet Gynecol 1993; 83:150-5. Silver RM, Draper ML, Scott JR, Lyon JL, Reading J, Branch DW. Clinical consequences of antiphospholipid antibodies: An historical cohort study. Obstet Gynecol, 1994;83:372-7. Mitchell MD, LaMarche S, Adamson S, Coulam C, Silver RM, Edwin SS. Regulation of intrauterine prostaglandin biosynthesis interactions between protein kinase C and interleukin 1Β. Prost Leuk EFA 1994;50:137-40. Silver RM, Edwin SS, Trautmna MS, Simmons DL, Branch DW, Dudley DJ, Mitchell MD. Bacterial lipopolysaccharide mediated fetal death: Production of a newly-recognized form of inducible cyclooxygenase (COX-2) in murine deciduas in response to lipopolysaccharide. J Clin Invest 1995;93:725-31. Silver RM, Pierangelli SS, Gharavai AE, Harris EN, Edwin SS, Salafia CM, Branch DW. Induction of high levels of anticardiolipin antibodies in mice by immunization with Β2-glycoprotein 1 does not cause fetal death. Am J Obstet Gynecol 1995;173L1410-5. Silver RM, Porter TF, van Leeuwen I, Coulam C, Jeng G, Scott JR, Branch DW. Anticardiolipin antibodies: Clinical consequences of low titers. Obstet Gynecol 1996;87:494-500. Oshiro BT, Silver RM, Scott JR, Yu H, Branch DW. Antiphospholipid antibodies and fetal death. Obstet Gynecol 1996;87:489-93. Edwin SS, Branch DW, Scott JR, Silver RM, Dudley DJ, Mitchell MD. Cyclosporin A inhibits prostaglandin E2 production by fetal amnion cells in response to various stimuli. Prostaglandins 1996;52:51-61. Branch DW, Silver RM. Criteria for antiphospholipid syndrome: early pregnancy loss, fetal loss, or recurrent pregnancy loss? Lupus 1996;5:409-13. Branch DW, Silver RM, Pierangeli SS, van Leeuwen I, Harris EN. Antiphospholipid antibodies other than lupus anticoagulant are not associated with recurrent pregnancy loss. Obstet Gyencol 1997;89:549-55. Silver RM, Edwin SS, Umar F, Dudley DJ, Branch DW, Mitchell MD. Bacterial lipopolysaccharide-mediate fetal death: The role of interleukin-1. Am J Obstet Gynecol 1997;176:544-9. Silver RM, Pierangeli SS, Edwin SS, Umar F, Harris EN, Scott JR, Branch DW. Pathogenic antibodies in women with obstetric features of antiphospholipid syndrome who test negative for lupus anticoagulant and anticardiolipin antibodies. Am J Obstet Gynecol 1997;176:628-33. Silver RM, Smith LA, Edwin SS, Oshiro BT, Scott JR, Branch DW. Variable effects of immunoglobulin G fractions from women with antiphospholipid antibodies on murine pregnancy. Am J Obstet Gynecol 1997;177:229-33. Coulam CB, Clark DA, Beer AE, Kutteh WH, Silver RM, Kwad J, Stephenson M. Current clinical options for diagnosis and treatment of recurrent spontaneous abortion. Am J Reprod Immunol 1997;38:57-74. Edwin SS, Mitchell MD, Silver RM, Branch DW, Dudley DJ. Ceramide stimulates prostaglandin production by human amnion and decidual cells J Soc Gynecol Invst 1997;4:274-8. Gharavi AE, Cucurull E, Tang H, Silver RM, Branch DW. Effect of antiphospholipid antibodies on beta-2-glycoprotein I-phospholipid interaction. Am J Reprod Immunol 1998;39:310-5. Kutteh WH, Rote NS, Silver RM. Antiphospholipid antibodies and reproduction. Am J Reprod Immunol 1999;41:133-154. Pregnancy loss study group (Branch DW, Druzin M, El-Sayed Y, Esplin MS, Hrager J, Peaceman AM, Silver RK, Silver RM, Spinnato J). A multicenter, controlled, pilot study of intravenous immune globulin treatment antiphospholipid syndrome in pregnancy. Am J Obstet Gynecol 2000;182:122-7. Van-Horn JT, Craven C, Ward K, Branch DW, Silver RM. Histologic features of gestational tissues from women with antiphospholipid and antiphospholipid-like syndromes. Placenta 2004;25:642-8. Ornoy A, Chen L, Silver RM, Mosmann TR, Miller RK. Maternal autoimmune diseases and immunologically-induced embryonic and feto-placental damage. Birth Defects Res Part A Clin Mol Teratol 2004;70:71-81. Frias AE, Luikenaar RA, Sullivan AE, Porter TF, Branch DW, Silver RM. Poor obstetric outcome in subsequent pregnancies in women with prior fetal death. Obstet Gynecol 2004;104:521-6. Sullivan AE, Silver RM, LaCoursiere DY, Porter TF, Branch DW. Does recurrent aneuploidy contribute to recurrent miscarriage? Obstet Gynecol 2004;10:784-8. Sullivan AE, Nelson L, Rice JA, Porter TF, Branch DW, Silver RM. The factor V Leiden and the G20210A prothrombin gene mutations are rare in women with fetal death. Am J Reprod Immunol 2005;54;1-4. Sullivan AE, Nelson L, Silver RM, Frias AE, Porter TF, Branch DW. The aryl hydrocarbon receptor nuclear tranlsocator gene polymorphism in patients with recurrent miscarriage. Am J Reprod Immunol 2006;55(1): 51-3 Silver RM, Landon MB, Rouse DC, Leveno JK, Spong CY, Thom EA, et al. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol 2006;107(6): 1226-32. Silver RM. Fetal Death. Obstet Gynecol 2007;109(1):153-67. Silver RM, Varner MW, Reddy U, Goldenberg R, Pinar H, Conway D, Bukowski R, Carpenter M, Hogue C, Willinger M, Dudley D, Saade G, Stoll B. Work-up of stillbirth: a review of the evidence. Am J Obstet Gynecol 2007;196:433-44. Warren JE, Silver RM, Nelson L, Dalton J, Porter TF, Branch DW. Cervical insufficiency: a genetic condition? Collagen 1?1 intron SP1 and transforming growth factor-? ARG-25-PRO polymorphisms in women with cervical insufficiency. Obstet Gynecol 2007;110:619-24. Raju TN, Nelson KB, Ferriero D, Lynch JK; NICHD-NINDS Perinatal Stroke Workshop Participants. Pediatrics 2007;120:609-16. Holmgren C, Esplin MS, Hamblin S, Esplin MS, Molenda M, Silver RM. Evaluation of the use of anti-TNF-alpha in an LPS-induced murine model. J Reprod Immunol 2008; Epub, April 21. Silver RM. New anticoagulants and pregnancy. Obstet Gynecol 2008;112:419-20. Silver RM. Immune activation early in pregnancy: trouble down the road. Am J Obstet Gynecol 2008, 199;327-8. Holmgren C, Porter TF, Varner MW, Aagard K, Silver RM. Hyperemesis in pregnancy: A comparison of treatment strategies. Am J Obstet Gynecol, 2008;198:56e1-4. Turok DK, Gurtcheff S, Esplin MS, Shah M, Simonsen SE, Shah M, Trauscht-Van Horn J, Silver RM. Second trimester termination of pregnancy: A review by site and procedure type. Contraception 2008;77:155-61 Peltier MR, Faux DS, Hamblin SD, Cooper C, Silver RM, Esplin MS. Effect of aspirin treatment on TNF-? Production by women with a history of preterm birth. J Reprod Immunol 2009;80:109-14. Warren JE, Silver RM, Branch DW, Porter TF. Thromboprophylaxis and pregnancy outcomes in asymptomatic women with thrombophilias. Am J Obstet Gynecol 2009;200:281.e1-5. Warren JE, Nelson L, Esplin MS, Silver RM. Interleukin-10 polymorphisms and cervical insufficiency. Am J Obstet Gynecol 2009;201:372-4. Manuck TA, Eller AG, Esplin MS, Stoddard G, Varner MW, Silver RM. Outcomes of expectantly managed preterm premature rupture of membranes occurring ? 24 weeks gestation. Obstet Gynecol 2009;114:29-37. Reddy UM, Goldenberg R, Silver R, Smith GCS, Pauli RM, Wapner RJ, et al. Stillbirth classification: developing an international consensus for research: Executive summary of NICHD workshop. Obstet Gynecol 2009;114:901-14. Manuck TA, McLean, Varner MW, Silver RM. Preterm premature rupture of membranes: does the duration of latency influence neonatal outcome? Am J Obstet Gynecol 2009;201:414-6. Warren JE, Turok DK, Maxwell TM, Brothman AR, Silver RM. Array comparative genomic hybridization (aCGH) for genetic evaluation of fetal loss between 10 and 20 weeks gestation. Obstet Gynecol 2009;114:1093-1102. Clark EAS, Lacoursiere DY, Byrne JLB, Ponder R, Silver RM, Esplin MS. Reliability of fetal MCA velocity: a randomized controlled trial of sonographer training. J Ultrasound Med 2009;28:19-25. Grosvenor Eller A, Silver RM, Zempolich K, Soisson P, Simonson SE. Optimal management of placenta accreta. Br J Obstet Gynecol 2009;116:648-54. Peltier MR, Faux DS, Hamblin SD, Silver RM, Esplin MS. Cytokine production by peripheral blood mononuclear cells of women with a history of preterm birth. In press, J Reprod Immunol. Silver RM, Zhao Y, Spong C, Caritis SN, Sibai B, Wendel G Jr., et al. Prothrombin gene G20210A mutation and obstetric complications: a prospective cohort. In press, Obstet Gynecol. C. Research Support Ongoing Support NIH/NICHD 1U10HD063053-01 Preterm Birth in Nulliparous Women: An Understudied Population (Silver)12/01/2009-11/30/2014 This Network will design and execute a prospective, longitudinal cohort study of 10,000 nulliparous women. The research protocols developed will determine characteristics that influence and/or predict adverse pregnancy outcomes in nulliparous women including genetics, epigenetics, physiological response to pregnancy, interaction with environmental exposures, fetal growth and development, and placental development and function. Role: PI NIH/NICHD 3U10HD045944-05S2 Research on the Scope and Causes of Stillbirth in the United States (Silver)09/26/2003–07/31/2009NCX The major goals of this project are to develop a network of collaborating academic centers to study the extent and causes of stillbirth and to develop methods for stillbirth prevention. Role: PI NIH/NICHD HHSN267200603423C / N01DK63423 (Silver)09/30/2006-09/29/2011 The Effects of Aspirin in Gestation and Reproduction The purpose of this contract is to evaluate the effect of daily low-dose aspirin on all phases of reproduction beginning at preconception and continuing throughout pregnancy, including implantation and live births. Role: PIRead More
9 November 2004 Dear Dr Luthra, I acknowledge with thanks your letter of 20 October 2004, introducing your Organization. We have taken due note of your initiative. Please be advised, however, that as UNESCO is mainly devoted to the promotion of intellectual cooperation in education, science, culture and communication, it would seem more appropriate for you to contact the World Health Organization, WHO, which should be able to help you in connection with your request which focuses on health related issues. Thanking you for your interest in UNESCO and wishing you every success in your activities, I remain, Yours sincerely, Massoud Abtahi Chief Section of International Non-Governmental Organizations and FoundationsRead More
Date of Birth: 10 December, 1945 Military: United States Navy 1975-1977, Naval Hospital, Beaufort, S.C. Education: Union College, Schenectady, NY B.S. (Biology) 1966Albany Medical College, Albany, NY (M.D.) 1970Internship- Albany Medical Center Hospital 1970-1971Residency- Albany Medical Center Hospital 1971-1973Fellow- Infectious Diseases, Albany Medical College 1973-1975 Certified: National Board of Medical Examiners- 1971American Board of Internal Medicine- 1973 Licensed: New York, Massachusetts Professional Societies: American Society for MicrobiologyInfectious Disease Society of AmericaMassachusetts Infectious Diseases SocieryAmerican Foundation for Infectious DiseasesAmerican Medical AssociationOutpatient Intravenous Therapy AssociationH.I.V. Medical Association Affiliations: Chief of Infectious Diseases, Division of Internal Medicine, Mercy Medical Center, Springfield, MAClinical Assistant Professor of Medicine, Tufts University College of MedicineVisiting Instructor in Public Health, University of Massachusetts, Amherst, MA 1989-1990Member, Division of Infectious Diseases, Baystate Medical Center, Springfield, MAConsultant in Infectious Diseases, Mercy Hospital, Springfield, MAHolyoke Hospital, Holyoke, MA, Noble Hospital, Westfield, MA, The Rehabilitation Hospital of Western Massachusetts, Ludlow, MAChairman, Infection Control: Mercy Hospital, The Rehabilitation Hospital of Western MassachusettsMedical Advisory Committee- Visiting Nurse Association of Holyoke Massachusetts Business: Medical Director, PROTOCARE of Massachusetts 1986-1997 Employment: Hampden County Medical Group, 1977-1979Springfield Medical Associates, 1979-1999Robert P. Hoffman MD, P.C. 1999- present Pharmaceutical Companies: Clinical Consultant in Infectious Diseases and H.I.V. Care: Merck, Hoffmann- LaRoche, Glaxo, Abbott, Agouron, Ortho-McNeil, Bristol Myers Squibb Recent Papers Presented: Current Issues in H.I.V./A.I.D.S.- March 7, 1999, West Springfield, MAInfections in Long Term Care- Western Massachusetts Hospital, Westfield, MA, June 2, 1999Cost-Effective Antibiotic Use- Mercy Hospital, Springfield, MA, June 8, 1999Salvage Therapy in H.I.V. Care- St. Petersberg, Florida, July 7, 1999OPAT in the Era of Managed Care- Mercy Hospital, Springfield, MA, September 9, 1999Salvage Therapy in Patients with Drug Resistant H.I.V.- Worcester, MA, October 7. 1999Antibiotic Associated Colitis and other Gastrointestinal Complications of Antibotic Use- Mercy Hospital, Springfield, MA, November 16,1999Influenza- What Is It and What Can We Do About It?- Springfield, MA, December 9, 1999Line Sepsis-How Do We Identify It, How do We Treat It?- Mercy Hospital, Springfield, MA, March 21, 2000African A.I.D.S.- Ugly Pictures in a Beautiful Setting- Mercy Hospital, Springfield, MA, October 10, 2000H.I.V. and the African American Community- Springfield, MA, March 5, 2001Community Acquired Pneumonia- applying Science to Practice-Springfield, MA; November 14, 2000Community Acquired Pneumonia- Mercy Hospital, Springfield, MA, May 12, 2001A Change of HAART- E. Longmeadow, MA, May 17, 2001CAP- A New Paradigm- Tufts Health Plan- October 19, 2001, Holyoke, MABioterrorism and the Physician- West Springfield, MA, Dec. 6, 2001AIDS in Africa- Sad Pictures in a Beautiful Place- Springfield, MA, February 6, 2002Less is More- A Change of HAART- Waterbury, CT, April 9, 2002 Symposia Moderated: Infectious Diseases Updated- 1983, Springfield, MAInfection Control Update- 1984, Springfield, MATopics in Infection Control- 1985, Springfield, MATopics in Infection Control- 1986, Springfield, MAHome Care in the ’90’s- High Tech and Compassion- Springfield, MAIntrroduction to Home Care- Hoffmann- LaRoche Home Health Services, Mahwah, NJ, February 22, 1989Antibiotics and Fever- April 4, 1990Common Infections: Contemporary Management Strategies-April 25, 1991Common Infectious Diseases- April 9, 1992. Springfield, MAQuality Assurance in Home Care- April 17, 1993, OPIVITA Conference, Chicago, IL Books Reviewed: Interpretation of Clinical Laboratory Data, American Society of Hospital Pharmacists, (ASHP), Bethesda, MD, 1990 Papers Published: «Quality Assurance of Protocare of Masasachusetts», OPIVITA, Oct. 1991«Valuing Outpatient Management Services», OPIVITA, December, 1991«Managed Care and the Infectious Diseases Specialist», Clinical Infectious Diseases, Vol. 23, No. 2, August, 1996In Preparation: «Outcomes of H.I.V. Care in a Community Based Practice-1998-1999»Merck Protocol 094/CRX463 (Direct study)- A Study of the Effectiveness and Side Effects of Indinavir-Ritonavir Combination.Glaxo (Zorro study)- To Assess the Tolerability and Safety of Ziagen in H.I.V.-I Infected Individuals.Agouran AG1700-1170- A Study to Assess the Ability of Delaviradine to Improve Lipid Profiles in H.I.V. Infected Individuals. Textbooks: Handbook of H.I.V., Total Learning Concepts, Boston, MA 2002Read More
President Women’s Health and Education Center (WHEC) NGO in Special Consultative Status with the Economic and Social Council of the United Nations e-mail: Rita@WomensHealthSection.com Dr. Rita Luthra is President of The Women’s Health and Education Center (WHEC) which is NGO (non-governmental organization) in Special Consultative Status with the Economic and Social Council of the United Nations. It is also affiliated with the World Health Organization (WHO), PMNCH (Partnership for Maternal and Child Health at WHO), The Economic and Social Council (ECOSOC), UN Department of Public Information ( UN DPI), UN Women, UN University (UNU), UN Foundation (UNF), and Every Woman Every Child Global Strategy initiative of the UN Secretary-General. Established in 2001, The Women’s Health and Education Center (WHEC) undertakes initiatives with the United Nations (UN) and the World Health Organization (WHO), to achieve the hopes and dreams of Sustainable Development Goals (SDGs), with special focus on Maternal and Child Health. Dr. Luthra has worked with various international organizations, such as the UNA-USA, Peace Corps, Population Council and World Health Organization. Dr. Luthra’s main interest is international health and development. She has 25 years of expertise in the project/program development at the National and International levels with various respectable international organizations, and innovative health technology systems such as telemedicine, online distance education and various e-Health management systems. The use of information science and telecommunications to support the practice of medicine when distance separates the caregiver from the patient is the way forward to make medical care more affordable and more accessible in every country. A strong and vital health workforce is an investment in health for today and the future. It has profound effect on all the citizens of the world, political, social, and economic systems. There are 3 leading purposes of the health-related uses of information and communication technologies (ICT) in low- and middle-income countries: To extend geographic access to health care; To improve data management; and To facilitate communication between patients and physicians outside the physician’s office. In 2018 at High Level Political Forum (HLPF), Dr. Luthra presented WHEC Global Health Line’s (WGHL’s) LINK (Learning and Innovation Network for Knowledge Solutions) Access Project – To provide access to reproductive health research worldwide, at UN Headquarters, NYC, New York (USA). Available @ UN Web TV: http://webtv.un.org/watch/player/5807660229001 Dr. Luthra was born and grew up in Rajasthan, India and currently resides in Massachusetts, USA. She received her education and medical degree (Bachelor of Medicine and Bachelor of Surgery) M.B.B.S. from University of Rajasthan, Jaipur (India) in 1974. M.D. (Doctor of Medicine) in Obstetrics and Gynecology, in 1978 from The Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh (India). After finishing the residency in Obstetrics and Gynecology at St. Elizabeth’s Medical Center, Boston, MA (USA) she received Fellowship in Obstetrics and Gynecology from the American College of Obstetrics and Gynecology, in 1986. She practiced Obstetrics and Gynecology mostly in Massachusetts (USA) till November 2015. Currently working with the UN and WHO on various initiatives to achieve Universal Health Care (UHC) and improve maternal and child health. Dr. Luthra is Editor-in-Chief of the e-learning publications: http://www.WomensHealthSection.com and WHEC Update. The initiatives of WHEC are also posted on CSO Net (Civil Society Net) under Best Practices and Projects on World Map ID # 364, title: Continuing Medical Education for the Globalized World. http://www.WomensHealthSection.com – knowledge that touches patients, is a vision for the globalized world. Please visit our Letters of Support Page: http://www.womenshealthsection.com/whec/letters We welcome everyone. Dedicated to Women’s and Children’s Healthcare and Wellbeing WorldwideRead More
El objetivo de la Salud de la Mujer y el Centro de Educación (WHEC) es apoyar y mejorar las oportunidades educativas y de salud general de las mujeres y en particular de las mujeres de los países en desarrollo. La salud de la mujer y la situación es muy compleja y difícil cuestión de los países en desarrollo y países industrializados de ambos. Las mujeres se enfrentan a enormes obstáculos – el prejuicio, el ostracismo, la violencia en el hogar, la pobreza, el hambre y casi no tienen acceso a atención médica y medicamentos que salvan la vida. La Salud de la Mujer y el Centro de Educación se dedica a la salud de la mujer y el bienestar de todo el mundo. Su sitio web, WomensHealthSection.com es con fines educativos, entre EE.UU. y los países en desarrollo: el beneficio mutuo y respeto mutuo. Apoyamos y proyectos / programas en la salud de la mujer, la educación y la investigación. Creemos: En esta ruta de esfuerzo nunca se pierde, y no hay fracaso. Cada año, más de 500, 000 mujeres mueren durante el embarazo o el parto y menos de 10 millones de niños mueren antes de cumplir cinco años-casi el 40% de ellos en el primer mes de vida. Pero la evidencia muestra que al menos 6 millones de estas vidas se pueden ahorrar cada año con el resultado, la relación coste-eficacia de las intervenciones. Nuestra Visión: Un mundo donde todas las mujeres y los niños reciban la atención que necesitan para vivir una vida sana y productiva. Nuestro Objetivo: invertir, ofrecer y promover la madre, el recién nacido y el niño, y, por tanto, el 50% de los 60 países con alta carga de morbilidad «en el buen camino» para lograr objetivos de desarrollo del Milenio 4 y 5 en 5 años. LO QUE HACEMOS Salud de la Mujer y el Centro de Educación (WHEC) aboga por la igualdad de género en la salud y la educación para las mujeres y las niñas de todo el mundo. WHEC trae la atención a las formas en que biológicos y los factores socioculturales que afectan la salud de mujeres y hombres, niños y niñas. WHEC tiene por objeto aumentar los conocimientos y fortalecer la respuesta del sector salud mediante la recopilación de pruebas, el fortalecimiento de la capacidad y la participación en las actividades de promoción sobre la forma de género y la desigualdad de género afectan a la salud. WHEC se centra en las formas en que las cuestiones de género, como una construcción social, afecta la salud de hombres y mujeres. Pero también nos damos cuenta de que la desigualdad de género tiene un peaje más alto en la salud de la mujer debido a la discriminación que sufren en casi todas las culturas. La desigualdad de género agrava los efectos perjudiciales de la pobreza y la falta de educación sobre la salud de la mujer, lo que dificulta la capacidad de millones de mujeres en todo el mundo para acceder a la atención de la salud y conseguir el mejor nivel posible de salud. WomensHealthSection.com educa a los profesionales de la salud acerca de las condiciones que son exclusivos de las mujeres, más frecuente en las mujeres, o son diagnosticados o tratados de manera diferente en las mujeres frente a hombres. Esta publicación presenta imparcial, completa y concisa, y clínicamente relevantes artículos de revisión y práctica secciones. Los artículos son revisados para mantener la más alta calidad y para comprobar la relevancia clínica, médicos de precisión y la claridad de la presentación. La más profunda y estimulante artículos ya están disponibles en un solo portal. Todos los Boletines WHEC práctica se revisan entre 18 y 24 meses después de la publicación y se revisan, se reafirmó, o retirarse. POR QUÉ DE GÉNERO Y LA SALUD Tanto las diferencias de género y las desigualdades de género pueden dar lugar a desigualdades entre hombres y mujeres en el estado de salud y el acceso a la atención de la salud. Por ejemplo: Una mujer no puede recibir los servicios de salud necesarios, porque las normas en su comunidad impedirle viajar solo a una clínica. Un adolescente muere en un accidente a causa de intentar estar a la altura de sus compañeros a las expectativas de que los hombres jóvenes deben ser «valiente» que asumen riesgos. Una mujer casada contratos VIH porque las normas de la sociedad fomentar la promiscuidad de su marido y al mismo tiempo que le impedía insistir en el uso del condón. Un país del índice de mortalidad por cáncer de pulmón de los hombres con mucho la tasa correspondiente a las mujeres porque el tabaquismo es considerado un marcador atractivo de la masculinidad, mientras que es mal vista unfeminine como en las mujeres. En cada uno de estos casos, las normas de género y valores, y comportamientos como resultado, se afecta negativamente la salud. De hecho, la imagen de género en un determinado momento y el lugar puede ser uno de los principales obstáculos – a veces el obstáculo más importante – de pie entre el hombre y la mujer y el logro del bienestar. WHEC ha producido una serie de páginas de información sobre la pertinencia de las cuestiones de género a varios problemas de salud concretos. A través de la lectura es una buena manera de comenzar a tener un sentido de las formas de género y de salud interactúan. WomensHealthSection.com es una compañía global, para la Web plataforma para múltiples formas de colaboración. Esta plataforma permite a los individuos, grupos, empresas, universidades y en cualquier lugar del mundo a colaborar – en el sentido de la innovación, la educación, la investigación y para promover la causa de paz, la salud y el desarrollo. Te invitamos a aprovechar esta plataforma, y, por último, la gestión para obtener los mejores resultados de esta plataforma.Read More
Director of Prenatal Diagnosis and Fetal Therapy Unit Assistant Professor of Obstetrics and Gynecology Department of Gynecological Science and Human Reproduction, Section of Maternal and Fetal Medicine University of Padua School of Medicine via Giustiniani N 3, Padua, 35128, Italy Phone: +39-339-8146745 Fax: +39-049-8211842 email: ecosmi@hotmail.com Erich Cosmi was born in Rome, Italy on December 1st, 1973. He entered the school of Medicine and Surgery at the University of Rome «La Sapienza», Rome, Italy in the 1993-1994 academic year, and was graduated on July 13th, 1999 summa with Laude, discussing his scientific work entitled: new therapeutical prevention of NRDS by in-utero surfactant administration. During his scholarship, Erich Cosmi was invited for three consecutive periods (1994-1996-1998), each period lasting three months, at the Yale University School of Medicine, Connecticut, USA, where he worked with Dr. Gabor Huszar in the Physiology Sperm laboratory and entered in a Research program concerning Reproductive Medicine. During his scholarship in Italy he attended as a student in the following Departments: Department of Anatomy: 1994-1995 Department of Pediatric Surgery: 1996-1997 Department of Anesthesiology: 1997-1998 Department of Obstetrics and Gynecology: 1998-1999 After his graduation in Medicine he attended the rotation as a Medical Doctor for 6 months in Internal Medicine, General Surgery, Pediatric and Ob/Gyn, Emergency and intensive Care Unit Departments. In the academic year of 1999-2000 he entered the residency school in Ob/Gyn at the University of Rome «Tor Vergata», Rome, Italy. In April 2001 he was appointed Assistant Professor in the Department of Obstetrics and Gynecology at the Virginia University (USA) School of Medicine for 3 years, were he was involved in many research projects in maternal-fetal medicine. From 2001 to 2004 was appointed Assistant Professor of Obstetrics and Gynecology and Associate Chief of MFM at the University of Sassari School of Medicine (Italy). He is assistant researcher at the Yale University School of medicine, Connecticut, USA. He is supervisor for Fetal Anemia at the University of Rome La Sapienza, Rome, Italy. From September 1st 2001 he was appointed as Assistant Professor of Obstetrics and Gynecology in University of Sassari School of Medicine, Italy. Till November 2001 he was involved with the residency program development in Obstetrics and Gynecology at the University of Sassari School of Medicine. From November 1st 2004 he was appointed Assistant Professor of Obstetrics and Gynecology in University of Padua School of Medicine. Erich Cosmi is author of 220 publications, with Impact Factor of 135, Citation Index of 324 and H- index of 10. From 2005 is Visiting Professor at the III University of Athens, Greece. From 13/09/05 is Tresourer and Counselor of the Italian Society of Maternal Fetal Medicine. International Member of the International Society of Ultrasound in Obstetrics and Gynecology from 2000; Member of The American Institute of Ultrasound in Medicine from 2005. Honorary Member of The Academy of Medicine of Serbia Montenegro. Expert Referee for ECM in Medicine appointed from 2005 by the Ministry of Health. From 2007 he is listed in the following encyclopedias: Who is Who in the World, Who is Who in Science and Engineering, Who is Who in America. From 2007 he is Director of the prenatal diagnosis and fetal therapy Unit in the Department of Obstetrics and Gynecology at Padua University.Read More
Address Telephone Number UMA 4581 402-559-4212 – office 983255 Nebraska Medical Center 402-559-5015 – office fax Omaha, NE 68198-3255 Email: nagarwala@unmc.edu USA Objective Providing comprehensive gynecological and urogynecological care, and participating in student, resident teaching along with research and surgical activities. Special Interests Laparoscopic Hysterectomy and Myomectomy. Laparoscopic Management of Pelvic Pain and Endometriosis. Laparoscopic and vaginal Urinary Incontinence Procedures. Laparoscopic and vaginal Pelvic Prolapse Procedures. Laparoscopic Infertility Surgery. Laparoscopic Lysis of Adhesions. Interstim placement for Intractable urgency, frequency. Education and Training Fellowship in Advanced Laparoscopic and Urogynecological Surgery, sponsored by American Association of Gynecological Laparoscopists (AAGL) and Society of Reproductive Medicine (SRM), Preceptor : Dr. C.Y. Liu, M.D., Director, Chattanooga Women’s Laser Center. 7/2001-7/2002. PGY 4, Chief Resident, OB/GYN, Penn State Geisinger Health System, Danville. 7/99 -6/2000 PGY 2-3, Obstetrics & Gynecology, Penn State Geisinger Health System, Danville. 6/97 -6/99. PGY-2, Obstetrics and Gynecology, University of California at Los Angeles. Aug 96 – Nov 96. PGY-1, Obstetrics and Gynecology, University of California at San Francisco. June 95- July 96. M.D., Milton S. Hershey Medical Center, The Pennsylvania State University, May 1995. M.S., Molecular and Cell Biology, The Pennsylvania State University, 1990, G.P.A. – 4.0 / 4.0. B.Pharm., Pharmaceutical Sciences, Birla Institute of Technology, India.1986, G.P.A.- 3.94/4.0. Fellowship Training Extensive training in complex laparoscopic procedures with special emphasis on Endometriosis, Pelvic Floor Reconstruction, Urogynecologic and Reproductive Surgery procedures. Residency Training Excellent evaluations throughout the residency training. Developed strong interest in providing most compassionate and humane care to a multicultural and diverse population. Actively involved in resident and medical student teaching. Worked on clinical research topics such as evaluating the largest vertical pocket of amniotic fluid as an indicator of Amniotic Fluid Index. Observational training in advanced endoscopic surgery for one month with Drs. C.Y.Liu and C. Koh. Clinical Work Experience Assistant Professor, Dept of Obstetrics and Gynecology, Urogynecology and Advanced Laparoscopic Surgery, University of Nebraska Medical Center, Omaha, NE, Oct 2002 – current. Consultant for Labor and Delivery at Eastridge Hospital, Chattanooga, TN, Aug 2001-June 2002. Staff Physician at Nason Hospital, Roaring Springs, PA, July 2000-June 2001. Currrent Research Activities An Open-Label Study of the Efficacy and Safety of 5 and 10 mg Vesicare ( Solifenacin Succinate) in patients with Overactive Bladder Symptoms. VOLT Vesicare Open-Label Trial Principal Investigator for UNMC site. IRB approval # 290-04 FB. Comparison of Efficacy, Cost-Effectiveness, and Patient Satisfaction of Ondansetron or Granisetron plus Dexamethasone or Dexamethasone alone in Preventing Post-Operative Nausea and Vomiting. PONV Study Secondary Investigator and Primary surgeon. IRB approval # 156-03 FB Urethral Retro-Resistance Pressure correlation with Urodynamic Measurements in normal Females using Gynecare Monitorr Device – Residency Program Education. Laparoscopic Surgical and Urogynecological minimally invasive surgery evaluations. Clinical Advancement Activities Laparoscopic Task Force, Gynecology Representative at The Nebraska Medical Center Educational Speaker for Pfizer, Watson, Wyeth, Odyssey and Yamanouchi. Storz Hysteroscopic Advances, Boston, March 2005. SIS Summit – Multidisciplinary conference for biomaterials, Cook Biotech., Santa Fe, March 2005. Speaker’s Bureau program for Odyssey, February 2005. Gynecare TVT-O Training Program, January 2004. Boston Scientific Innovations in Pelvic Floor Reconstruction and Stress Urinary Incontinence Program, September 2004. Interstim Therapy Training Program, August 2003. Cook Stratasis Mentor Program, June 2003. Research Work Experience Research Scientist, October 1986-August 1991, Zetachron, Inc., State College, Pennsylvania. Co-Inventor on two U.S. patents for sustained release super cooling drug formulations and enteric acting dosage forms. Designed and developed dosage forms for controlled-release oral and buccal delivery systems for drugs under these categories: analgesics, antihypertensives, CNS stimulants, bronchodilators, antiemetics, antihistamines, antibiotics, hormones, and vitamins.Worked on stability and kinetics of new dosage forms using dissolution apparatus, spectrometry, chromatography, and pH meters. M.S. Thesis on Parathyroid Hormone receptors on osteoclasts, June 1989 – December 1990. Used gel chromatography, iso-electric focusing, advanced light and fluorescence microscopy. Presented a poster and a seminar on this research work at a graduate research exhibition and at the American Society for Cell Biology meeting. Graduate coursework: Neurophysiology, Evaluation of Cell Functions, Molecular Biology and Cell Regulation, Tumor Virology and Oncology, Carbohydrates, and Mathematical Methods. Academic Honors and Awards Earned academic grade of honors and excellent evaluations in all clerkships during the third and forth year of medical school. High scores on all. National Board Subject Examinations for clerkships (93rd-100th percentile). Consistently achieved honors grade and top rank in almost all courses, both basic science and clinical, during the first two years of medical school. AWARDS Jerome J Hoffman Postgraduate Prize at the AAGL 33rd Annual Meeting, San Francisco, November 2004. Best Fellow Award -2002 at The Chattanooga Women’s Laser Center by Hospital and OR Staff. Best Resident Teaching Award for 1999-00 at PSGHS by Thomas Jefferson Medical Student Committee Selected for the 1999 ACOG Wyeth-Ayerst Resident Reporter Program for ACOG Berlex Laboratories PGY-2 Best Teaching Resident Award for 1997-98 at PSGHS Selected for the 1998 CREOG/Wyeth-Ayerst Educational Resident Reporter Program. Alpha Omega Alpha Medical Honor Society, elected during the junior year of medical school Hammond Award for outstanding academic performance in the first, second, and third year of medical school. Only student in medical school class to win the award for three consecutive years Virchow Prize for excellence in Pathology from the Department of Pathology in 1993 First Rank holder in thel 986 batch of B.Pharm students and University-wide gold medalist G.P. Nair Award from the Indian Drug Manufacturers Association in 1986. Publications Agarwala, N. Laparoscopic hysterectomy for morbidly obese patients, Submitted for presentation at the AAGL 34th Annual Meeting Agarwala, N., Cohen, A. Experience with Laparoscopic Hysterectomy in a teaching University Hospital. Submitted for presentation at the AAGL 34th Annual Meeting Agarwala, N. Laparoscopic bilateral uterosacral ligament suspension for vaginal prolapse. Submitted for presentation at the AAGL 34th Annual Meeting Agarwala, N, Briggs, A,. Laparoscopic Sacral Colpopexy for recurrent vault prolapse, Video presentation for the AAGL 34th Annual Meeting Agarwala, N. To compare synthetic and biologic materials for tension free sling in women with stress incontinence. Presented at American College of Obstetricians and Gynecologists’ 53rd Annual Clinical Meeting, May 2005. Agarwala, N. Ortiz, A., Colpocleisis and tension-free vaginal sling for pelvic prolapse and stress urinary incontinence. Presented at American College of Obstetricians and Gynecologists’ 53rd Annual Clinical Meeting, May 2005. Agarwala, N. To identify urodynamic characteristics of long term Burch colposuspension failures. Presented at American College of Obstetricians and Gynecologists’ 53rd Annual Clinical Meeting, May 2005. Agarwala, N., Liu, C.Y. Safe entry Techniques During Laparoscopy: Left Upper quadrant Entry Technique Using the Ninth Intercostal Space – A Review of 918 Cases. The Journal of Minimally Invasive Surgery, Vol 12, No 1, 55-61. Agarwala, N., Liu, C.Y. To evaluate biomaterials for mid-urethral sling procedures. American College of Obstetricians and Gynecologists’ 52nd Annual Clinical Meeting, May 2004. Agarwala, N. Simple technique for reduction of post-operative gas pain after Laparoscopy. American College of Obstetricians and Gynecologists’ 52nd Annual Clinical Meeting, May 2004. Agarwala, N., Liu, C.Y. Laparoscopic Uterosacral Vault or Uterine suspension: Our experience. The Journal of the American Association of Gynecologic Laparoscopists, Vol. 10, No. 3 Supplement, Aug 2003. Agarwala, N., Liu, C.Y. Minimally Invasive Management of Stress Urinary Incontinence. Current Opinions in Obstetrics and Gynecology. October 2002. Agarwala, N., Liu, C.Y. Laparoscopic Appendectomy – A review of 317 cases. The Journal of the American Association of Gynecologic Laparoscopists, 10(2), 166-168, 2003. Agarwala, N., Liu, C. Y. Long term results of Laparoscopic Burch Colposuspension. Submitted to The Journal of American Association of Gynecologic Laparoscopists. Agarwala, N., Liu, C. Y. Urinary Incontinence in Women and Current Treatments. Chapter for a book published in Argentinia. Agarwala, N., Nair, S.G., Ghosh, T.K. Experience with Neoadjuvant Methotrexate, Vincristine, Adriamycin, Cisplatin (MVAC) in Locally Advanced Cervical Carcinoma Proceedings of American Society of Clinical Oncology 2000; vol.19; 9: 1569. Agarwala, N and Gay, C.V. Specific Binding of Parathyroid Hormone to Living 0steoclasts. Journal of Bone and Mineral Research 1992; vol. 7; 9: 531-539. Snipes, W and Agarwala, N. The Molecular Basis of Human Disease and approaches to its treatment. Science and People – The Woodburn Press, 1993. ISBN 0-9612798-5-0. This book was intended for youngsters to motivate them to study life sciences, and for a large adult population that had little knowledge of human diseases. Continuing Medical Education American College of Obstetricians and Gynecologists, 53rd Annual Clinical Meeting, San Francisco, May, 2005. International Congress of Gynecologic Endoscopy AAGL 33rd Annual Meeting, San Francisco, November, 2004 American College of Obstetricians and Gynecologists, 52nd Annual Clinical Meeting, Philadelphia, May, 2004. International Congress of Gynecologic Endoscopy AAGL 32nd Annual Meeting, Las Vegas, November, 2003 PG Courses: Complications of Laparoscopic Surgery, Hysterectomy Alternatives. Plenary session speaker: Laparoscopic Uterosacral Vault or Uterine Suspension Osler Institute Review Course in Obstetrics and Gynecology, Philadelphia, May, 2003 International Congress of Gynecologic Endoscopy AAGL 31st Annual Meeting, Miami, November, 2002 PG Courses: Laparoscopic Surgery-Outer limits, Laparoscopic Pelvic Floor reconstruction. Plenary session speaker: Laparoscopic Appendectomy Experience. International Congress of Gynecologic Endoscopy AAGL 30th Annual Meeting, San Francisco, November, 2001 PG Courses: Laparoscopic Management of Endometriosis, Laparoscopic Urogynecology American College of Obstetricians and Gynecologists District III, 2000 Annual Meeting, Philadelphia, October, 2000 Poster Presentation: Experience with Neoadjuvant MVAC in Locally Advanced Cervical Cancer. Obstetrics and Gynecology Review Course, Chicago Area Schools of Medicine, Chicago, June, 2000. American Society of Clinical Oncology Poster Presentation: Experience with Neoadjuvant MVAC in Locally Advanced Cervical Cancer. Advances in Gynecologic Surgery and Oncology 36th Annual Clinical Meeting, New Orleans, May, 2000 Course Directors: Dr. Philip DiSaia and William T. Creaseman Seventeenth Annual Houston Everett Memorail Course in Urogynecology Course Director: Dr. Cundiff, Johns Hopkins, Baltimore, February, 2000 American College of Obstetricians and Gynecology ACOG 47th Annual Clinical Meeting, Philadelphia, May, 1999 Clinical Seminars: Preeclampsia and Hypertension: Prevention and Management, Gynecologic Oncology for the general OB/GYN, Management of abnormal pap smears. International Congress of Gynecologic Endoscopy AAGL 27th Annual Meeting, Atlanta, November, 1998 PG Courses: Pelvic Floor Reconstruction, Laparoscopic Hysterectomy Advances in Female Voiding Dysfunction and Pelvic Disorders Conducted by The Cleveland Clinic Foundation, October, 1998 Course Directors: Rodney A. Appell, M.D. and Mark D. Walters, M.D. Advanced Endoscopic Surgery with hands-on laparoscopy lab Conducted by AAGL and Ethicon Endo-Surgery Institute, August, 1998 Course Directors: Grace M Janik, M.D. and Charles H. Koh, M.D. Advanced Endoscopic Gynecologic Surgery with hands-on lapraroscopy lab Conducted by AAGL and Ethicon Endo-Surgery Institute, June, 1998 Course Directors: Mark W. Surrey, M.D., Thomas L. Lyons, M.D., and C. Y. Liu, M.D. All Michigan OB/GYN Review Course – May 18-22,1998 Advanced Gynecological Surgery Course Directors: Michael S. Baggish, M.D. and John L. Marlow, M.D., January, 1998 Advances in Gynecology: Modem Management of Uterine Fibroids and Endometriosis, Palm Springs,1995 Presentations Women’s Watch Program – Lecture on Urinary Incontinence in Women, May 2005. Cadaver Lab, Laparoscopic Principles Workshop, Urogynecology Procedures Resident Lecture Series, 2004-2005. It happens to the best of Us – Speaker at the Olson Center Brown Bag Lecture Series, University of Nebraska Medical Center, Omaha, April 2005. Management of Overactive Bladder- Trospium as a new medication– Speaker at Urology and Family Practice Groups, Sioux Falls, March, 2005. Urodynamic Principles, Resident Lecture Series, March, 2005. Urogynecological Surgery, Laparoscopic Hysterectomy and Menopause – Operating Room Personell Morning Lecture Series, University of Nebraska Medical Center, Three lectures in 2004 Management of Overactive Bladder – Speaker at Family Practice Grand Rounds, University of Nebraska Medical Center, Omaha, September 2004. Laparoscopic Hysterectomy – Wyeth Representative Teaching Program, March 2004. Advances in Hysteroscopic surgery – Grand Rounds, Department of Obstetrics and Gynecology, University of Nebraska Medical Center, March 2004. There is help for Incontinence – Nursing Students Educational Program, University of Nebraska, Omaha, April 2004-5. Management of Overactive Bladder – Speaker at four outreach programs, University of Nebraska Medical Center, Omaha, January- February 2004. There is help for Incontinence – Speaker at the Olson Center Brown Bag Lecture Series, University of Nebraska Medical Center, Omaha, January 2004. What’s New in Incontinence – Grand Rounds, Department of Obstetrics and Gynecology, University of Nebraska Medical Center, August 2003. Advanced Laparoscopy – Grand Rounds, Department of Obstetrics and Gynecology, University of Nebraska Medical Center, March 2003. Evaluation of Incontinence – 32nd, 33rd and 34th Annual Family Practice Review Course, Best practices for the 21st century, University of Nebraska Medical Center, April 2003-5. Surgical Anatomy, Laparoscopic Evaluation of the pelvis, Electrosurgical principles in surgery – Resident Lectures, Department of Obstetrics and Gynecology, University of Nebraska Medical Center, 2002-2003. Pelvic Organ Prolapse and Urinary Incontinence – 3rd year Student Lectures, Department of Obstetrics and Gynecology, University of Nebraska Medical Center, 2002-2005. Normal reproduction and Infertility – 2nd year Medical Student Lecture, College of Medicine, University of Nebraska Medical Center, 2002-2004. Normal menstrual cycle, Menorrhagia and Metrorrhagia – 2nd year Medical Student Lecture, College of Medicine, University of Nebraska Medical Center, 2002-2005. The menstrual cycle and abnormalities – Introduction to Medicine Lecture, Physician Assistant Program, University of Nebraska Medical Center, 2002-2004. There is help for Incontinence – Speaker at the Spring Women’s Conference, Renew, Refresh, Revive: A Day of Women’s Wellness, Omaha, March 2003. Common Medical Conditions of Aging – Speaker at the 6th Annual Omaha Women’s Health and Wellness Conference, October 2003. Surgical principles of Incontinence Surgery – Women’s Lecture Series at the Eastridge Hospital, Chattanooga, April 2002. Certification American Board of Obstetrics and Gynecology (ABOG) Oral Examination– completed in 12/04 Written examination for ABOG -completed in 6/2001. Completed United States Medical Licensing Examinations Step-I. II, and III. CREOG In-Training Examination-Standardized scores: 242 -PGY-1, 239 -PGY-2, 236 -PGY-3&4 Licensure Licensed to practice in the state of Pennsylvania, Nebraska and Tennessee Memberships The American Association of Gynecological Laparoscopists, The American College of Obstetricians and Gynecologists, American Medical Association, Alpha Omega Alpha, California Medical Association and Pennsylvania Medical Society, American Association for Advancement of Science.Read More
Your privacy on the Internet is of utmost importance to the Women’s Health and Education Center (WHEC). This privacy statement describes WHEC’s policy concerning the gathering and sharing of visitors’ information through the WHEC web site. It applies to all «WHEC sites» — that is, all sites within the «womenshealthsection.com» domain name. What information does WHEC collect? Normal web site usage: In general, you can browse the WHEC site without telling us who you are or revealing any personal information about yourself. The only information we gather during general browsing is from standard server logs. These include your IP (Internet Protocol) address, domain name, browser type, operating system, and information such as the web site that referred you to us, the files you download, the pages you visit, and the dates/times of those visits. Collection of personally identifiable information If you register for a newsletter, log on to certain WHEC sites, request information, provide feedback, join a discussion group or join an electronic mailing list, you will be asked to provide personal information such as your name, postal address and e-mail address. This information is collected only with your knowledge and permission, and is kept in various WHEC databases. WHEC sites with specific requirements to collect personal information may publish a privacy policy specific for that site. In these cases, the site-specific policies will be complementary to this general WHEC privacy policy, but will give additional details for that particular site. Joining electronic discussion groups may mean that other participants of the discussion group (including non-WHEC employees) will see personal information that you have volunteered. For open discussion groups, this information will be public. What does WHEC do with the information it collects? Normal web site usage: The information gathered during general browsing of the «womenshealthsection.com» domain is used to analyze trends and usage of the WHEC site and to improve the usefulness of the site. It is not connected with any personal information. Personally identifiable information WHEC may use the personal information you provide to: Contact you — either in response to a query or suggestion, or to mail newsletters, documents, publications etc. to you; «Remember» your online profile and preferences; Help you quickly find information that is relevant to you based on your interests, and help us create site content most relevant to you; Statistical analysis What if I don’t want to provide personal information? Providing personal information on the WHEC site is optional. If you choose not to provide personal information, you can still browse and use the WHEC site. Security We do not sell or share any personally identifiable information volunteered on the WHEC site to any third party. Any information provided to WHEC by users of the WHEC site is held with the utmost care and security, and will not be used in ways other than as set forth in this privacy policy, or in any site-specific policies, or in ways to which you have explicitly consented. WHEC employs a range of technologies and security measures to protect the information maintained on our systems from loss, misuse, unauthorized access or disclosure, alteration, or destruction. All our employees who have access to, and are associated with the processing of personal data, are obliged to respect the confidentiality of official business matters, including personal data. The WHEC site contains links to sites external to the womenshealthsection.com domain. WHEC is not responsible for the privacy practices or the content of such sites.Read More
